VISICU’s eICU(R) Program Coming to Resurrection Health Care
Resurrection Health Care (Chicago, IL) entered into an agreement with VISICU to implement their patented eICU® Program. The eICU Program will be part of Resurrection’s on-going commitment to ensure their patients receive the highest quality care. The eICU Program will provide coverage for 174 ICU beds in eight hospitals.
eICU technology combines early warning software and remote monitoring tools to enable off-site critical care physicians and nurses to support intensive care unit (ICU) staff in delivering proactive patient care. Demonstrated to provide significant reductions in mortality and length of stay, eICU technology in conjunction with the eICU care model enable hospitals to meet stringent patient care safety standards by ensuring all ICU patients receive continuous care from physicians and nurses who specialize in critical care.
“VISICU is proud to partner with Resurrection Health Care in implementing tools that support clinicians in delivering the highest caliber care to the sickest patients,” said Frank T. Sample, VISICU Chairman and CEO.
About VISICU
VISICU, Inc. (NASDAQ:EICU) is a healthcare information technology and clinical solutions company focused on transforming the delivery of critical care through its eICU® Program. The eICU Program restructures the practice of critical care by using remote monitoring technology to allow health systems to centralize scarce critical care trained staff to improve coverage and to intervene earlier to prevent or manage crises. A study (Crit Care Med 2004; 32:31-38) documented the clinical and financial benefits of the program. The eICU Program enables hospitals to meet The Leapfrog Group’s ICU patient care safety standards. For more information, visit www.VISICU.com. VISICU® and eICU® are registered trademarks of VISICU, Inc. All rights reserved. All other brand names, product names, company names, trademarks and service marks are the property of their respective owners.
Safe Harbor Statement
This release contains forward-looking statements that are made pursuant to the provisions of Section 21E of the Securities and Exchange Act of 1934, as amended. These forward-looking statements involve a number of risks and uncertainties. Investors are cautioned that statements in this release that are not strictly historical statements constitute forward-looking statements. It is important to note that the company’s performance, and actual results, financial condition or business could differ materially from those expressed in the forward-looking statements. The words “may”, “could”, “would”, “should”, “outlook”, “positions us”, “guidance”, “expects”, “estimates”, “intends”, “plans”, “projects”, “anticipates”, “believes”, “predicts”, “potential” or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could materially affect actual results, levels of activity, performance or achievements. Factors that could cause results to differ materially from current expectations include, but are not limited to: market acceptance of our principal product offering and any new product releases; the price, performance and reliability of our products and services; our ability to attract and retain new customers and renewal rates of our existing customers; unanticipated delays or problems in releasing new products and services; financial and budget constraints of hospitals, changes in our pricing practices or our competitors’ pricing practices and changes in the healthcare industry; the introduction or availability of competing products or services and other competitive factors; and changes in the government regulation of our products and services.